The American Journal of Managed Care

Choosing Wisely: Insights from an MAIC and eXalt3

Panelists discuss how matching-adjusted indirect comparisons (MAIC) of ALK inhibitors and the FDA approval of ensartinib in December 2024 influence frontline treatment selection for ALK+ non–small ...
The American Journal of Managed Care

Ibrutinib Shows Similar Efficacy Across Trials in Chronic Lymphocytic Leukemia

Matching-adjusted indirect comparison methodology was utilized to compare ibrutinib arms across the ALPINE and ELEVATE-RR trials. In each study, ibrutinib was used as the comparator for a ...
ascopubs.org

A pilot trial of multiple-TSA-specific adoptive immune cell (MAIC) as adjuvant therapy in gastrointestinal cancer.

Prospective analysis of antinuclear antibodies prevalence in a pan-tumor sample. Profiling antigen specificity concurrently with protein and mRNA quantification using high throughput single-cell ...
ascopubs.org

DEFENDOR SPECIAL: Effect of primary prophylaxis with empegfilgrastim on pCR rate after neoadjuvant TCHP in early HER2+ breast cancer patients—Matching-adjusted indirect ...

Efficacy and safety of trastuzumab deruxtecan for metastatic HER2+ and HER2-low breast cancer: A systematic review and meta-analysis of randomised controlled trials. MAIC of pCR in HER2+ eBC pts after ...